54.64 USD
+0.02 (+0.04%)
54.64 USD
0 (0%)
Taking everything into account, MDLZ scores 4 out of 10 in our fundamental rating. MDLZ was compared to 87 industry peers in the Food Products industry. MDLZ has an excellent profitability rating, but there are concerns on its financial health. MDLZ is valued expensive and it does not seem to be growing.
1. Profitability
1.1 Basic Checks
MDLZ had positive earnings in the past year.
In the past year MDLZ had a positive cash flow from operations.
In the past 5 years MDLZ has always been profitable.
In the past 5 years MDLZ always reported a positive cash flow from operatings.
1.2 Ratios
With a decent Return On Assets value of 4.95%, MDLZ is doing good in the industry, outperforming 75.86% of the companies in the same industry.
MDLZ has a Return On Equity of 13.49%. This is amongst the best in the industry. MDLZ outperforms 83.91% of its industry peers.
Looking at the Return On Invested Capital, with a value of 6.25%, MDLZ is in the better half of the industry, outperforming 68.97% of the companies in the same industry.
The Average Return On Invested Capital over the past 3 years for MDLZ is significantly below the industry average of 28.50%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROIC | 6.25% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
1.3 Margins
MDLZ's Profit Margin of 9.38% is amongst the best of the industry. MDLZ outperforms 87.36% of its industry peers.
In the last couple of years the Profit Margin of MDLZ has declined.
MDLZ has a better Operating Margin (11.59%) than 80.46% of its industry peers.
MDLZ's Operating Margin has improved in the last couple of years.
MDLZ has a Gross Margin of 31.05%. This is in the better half of the industry: MDLZ outperforms 73.56% of its industry peers.
In the last couple of years the Gross Margin of MDLZ has remained more or less at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% |
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is just above the Cost of Capital (WACC), so MDLZ is still creating some value.
MDLZ has less shares outstanding than it did 1 year ago.
The number of shares outstanding for MDLZ has been reduced compared to 5 years ago.
Compared to 1 year ago, MDLZ has an improved debt to assets ratio.
2.2 Solvency
An Altman-Z score of 2.24 indicates that MDLZ is not a great score, but indicates only limited risk for bankruptcy at the moment.
MDLZ has a Altman-Z score (2.24) which is comparable to the rest of the industry.
MDLZ has a debt to FCF ratio of 9.31. This is a negative value and a sign of low solvency as MDLZ would need 9.31 years to pay back of all of its debts.
MDLZ has a better Debt to FCF ratio (9.31) than 64.37% of its industry peers.
A Debt/Equity ratio of 0.76 indicates that MDLZ is somewhat dependend on debt financing.
MDLZ has a Debt to Equity ratio of 0.76. This is in the lower half of the industry: MDLZ underperforms 60.92% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Altman-Z | 2.24 |
ROIC/WACC0.84
WACC7.42%
2.3 Liquidity
MDLZ has a Current Ratio of 0.61. This is a bad value and indicates that MDLZ is not financially healthy enough and could expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 0.61, MDLZ is doing worse than 88.51% of the companies in the same industry.
A Quick Ratio of 0.37 indicates that MDLZ may have some problems paying its short term obligations.
With a Quick ratio value of 0.37, MDLZ is not doing good in the industry: 83.91% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 |
3. Growth
3.1 Past
MDLZ shows a strong negative growth in Earnings Per Share. In the last year the EPS decreased by -21.70%.
Measured over the past 5 years, MDLZ shows a small growth in Earnings Per Share. The EPS has been growing by 6.91% on average per year.
Looking at the last year, MDLZ shows a small growth in Revenue. The Revenue has grown by 4.13% in the last year.
MDLZ shows a small growth in Revenue. Measured over the last years, the Revenue has been growing by 7.09% yearly.
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
3.2 Future
Based on estimates for the next years, MDLZ will show a small growth in Earnings Per Share. The EPS will grow by 3.92% on average per year.
The Revenue is expected to grow by 3.83% on average over the next years.
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
3.3 Evolution
When comparing the EPS growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is decreasing.
4. Valuation
4.1 Price/Earnings Ratio
With a Price/Earnings ratio of 19.17, MDLZ is valued on the expensive side.
MDLZ's Price/Earnings ratio is in line with the industry average.
MDLZ's Price/Earnings ratio indicates a valuation a bit cheaper than the S&P500 average which is at 26.59.
MDLZ is valuated rather expensively with a Price/Forward Earnings ratio of 17.04.
MDLZ's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. MDLZ is cheaper than 65.52% of the companies in the same industry.
The average S&P500 Price/Forward Earnings ratio is at 24.03. MDLZ is valued slightly cheaper when compared to this.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.17 | ||
| Fwd PE | 17.04 |
4.2 Price Multiples
Compared to the rest of the industry, the Enterprise Value to EBITDA ratio of MDLZ is on the same level as its industry peers.
MDLZ's Price/Free Cash Flow is on the same level as the industry average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 30.79 | ||
| EV/EBITDA | 15.4 |
4.3 Compensation for Growth
MDLZ has a very decent profitability rating, which may justify a higher PE ratio.
PEG (NY)N/A
PEG (5Y)2.77
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
5. Dividend
5.1 Amount
With a Yearly Dividend Yield of 3.65%, MDLZ has a reasonable but not impressive dividend return.
Compared to an average industry Dividend Yield of 2.36, MDLZ pays a bit more dividend than its industry peers.
Compared to an average S&P500 Dividend Yield of 1.88, MDLZ pays a better dividend.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
5.2 History
The dividend of MDLZ is nicely growing with an annual growth rate of 10.52%!
MDLZ has been paying a dividend for at least 10 years, so it has a reliable track record.
MDLZ has not decreased their dividend for at least 10 years, which is a reliable track record.
Dividend Growth(5Y)10.52%
Div Incr Years11
Div Non Decr Years11
5.3 Sustainability
MDLZ pays out 69.92% of its income as dividend. This is not a sustainable payout ratio.
The dividend of MDLZ is growing, but the earnings are growing slower. This means the dividend growth is not sustainable.
DP69.92%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
54.64
+0.02 (+0.04%)
Chartmill FA Rating
GICS SectorConsumer Staples
GICS IndustryGroupFood, Beverage & Tobacco
GICS IndustryFood Products
Earnings (Last)
Earnings (Next)
Inst Owners89.33%
Inst Owner Change3.26%
Ins Owners0.15%
Ins Owner Change-0.01%
Market Cap70.51B
Revenue(TTM)37.65B
Net Income(TTM)3.53B
Analysts78.24
Price Target69.55 (27.29%)
Short Float %2.7%
Short Ratio3.69
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.65% |
Yearly Dividend1.76
Dividend Growth(5Y)10.52%
DP69.92%
Div Incr Years11
Div Non Decr Years11
Ex-Date
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)2.9%
Min EPS beat(2)0.24%
Max EPS beat(2)5.55%
EPS beat(4)3
Avg EPS beat(4)3.23%
Min EPS beat(4)-3.07%
Max EPS beat(4)10.18%
EPS beat(8)7
Avg EPS beat(8)5.65%
EPS beat(12)11
Avg EPS beat(12)5.57%
EPS beat(16)14
Avg EPS beat(16)5.23%
Revenue beat(2)0
Avg Revenue beat(2)-1.02%
Min Revenue beat(2)-1.64%
Max Revenue beat(2)-0.41%
Revenue beat(4)0
Avg Revenue beat(4)-1.62%
Min Revenue beat(4)-2.33%
Max Revenue beat(4)-0.41%
Revenue beat(8)0
Avg Revenue beat(8)-1.65%
Revenue beat(12)4
Avg Revenue beat(12)-0.26%
Revenue beat(16)7
Avg Revenue beat(16)0.39%
PT rev (1m)-4.44%
PT rev (3m)-7.31%
EPS NQ rev (1m)-0.42%
EPS NQ rev (3m)-14.92%
EPS NY rev (1m)-1.09%
EPS NY rev (3m)-4.16%
Revenue NQ rev (1m)-0.19%
Revenue NQ rev (3m)-1.56%
Revenue NY rev (1m)-0.16%
Revenue NY rev (3m)-0.56%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 19.17 | ||
| Fwd PE | 17.04 | ||
| P/S | 1.87 | ||
| P/FCF | 30.79 | ||
| P/OCF | 19.72 | ||
| P/B | 2.69 | ||
| P/tB | N/A | ||
| EV/EBITDA | 15.4 |
EPS(TTM)2.85
EY5.22%
EPS(NY)3.21
Fwd EY5.87%
FCF(TTM)1.77
FCFY3.25%
OCF(TTM)2.77
OCFY5.07%
SpS29.17
BVpS20.29
TBVpS-13.7
PEG (NY)N/A
PEG (5Y)2.77
Graham Number36.07
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 4.95% | ||
| ROE | 13.49% | ||
| ROCE | 8.75% | ||
| ROIC | 6.25% | ||
| ROICexc | 6.42% | ||
| ROICexgc | 45.17% | ||
| OM | 11.59% | ||
| PM (TTM) | 9.38% | ||
| GM | 31.05% | ||
| FCFM | 6.08% |
ROA(3y)5.83%
ROA(5y)5.83%
ROE(3y)14.91%
ROE(5y)14.57%
ROIC(3y)7.83%
ROIC(5y)7.26%
ROICexc(3y)8.08%
ROICexc(5y)7.6%
ROICexgc(3y)56.9%
ROICexgc(5y)49.07%
ROCE(3y)10.54%
ROCE(5y)9.74%
ROICexgc growth 3Y30.99%
ROICexgc growth 5Y25.82%
ROICexc growth 3Y12.8%
ROICexc growth 5Y10.57%
OM growth 3Y2.71%
OM growth 5Y2.05%
PM growth 3Y-5.45%
PM growth 5Y-3.59%
GM growth 3Y-0.05%
GM growth 5Y-0.42%
F-Score5
Asset Turnover0.53
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.76 | ||
| Debt/FCF | 9.31 | ||
| Debt/EBITDA | 3.47 | ||
| Cap/Depr | 96.19% | ||
| Cap/Sales | 3.42% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 62.74% | ||
| Profit Quality | 64.85% | ||
| Current Ratio | 0.61 | ||
| Quick Ratio | 0.37 | ||
| Altman-Z | 2.24 |
F-Score5
WACC7.42%
ROIC/WACC0.84
Cap/Depr(3y)93.3%
Cap/Depr(5y)88.79%
Cap/Sales(3y)3.26%
Cap/Sales(5y)3.28%
Profit Quality(3y)86.51%
Profit Quality(5y)84.12%
High Growth Momentum
Growth
EPS 1Y (TTM)-21.7%
EPS 3Y6.58%
EPS 5Y6.91%
EPS Q2Q%-26.26%
EPS Next Y-14.33%
EPS Next 2Y-3.59%
EPS Next 3Y0.49%
EPS Next 5Y3.92%
Revenue 1Y (TTM)4.13%
Revenue growth 3Y8.26%
Revenue growth 5Y7.09%
Sales Q2Q%5.87%
Revenue Next Year4.87%
Revenue Next 2Y4.39%
Revenue Next 3Y4.16%
Revenue Next 5Y3.83%
EBIT growth 1Y-29.74%
EBIT growth 3Y11.2%
EBIT growth 5Y9.29%
EBIT Next Year6.8%
EBIT Next 3Y6.69%
EBIT Next 5Y7.99%
FCF growth 1Y-34.14%
FCF growth 3Y3.52%
FCF growth 5Y2.99%
OCF growth 1Y-21.27%
OCF growth 3Y5.84%
OCF growth 5Y4.37%
MONDELEZ INTERNATIONAL INC-A / MDLZ FAQ
Can you provide the ChartMill fundamental rating for MONDELEZ INTERNATIONAL INC-A?
ChartMill assigns a fundamental rating of 4 / 10 to MDLZ.
What is the valuation status for MDLZ stock?
ChartMill assigns a valuation rating of 3 / 10 to MONDELEZ INTERNATIONAL INC-A (MDLZ). This can be considered as Overvalued.
What is the profitability of MDLZ stock?
MONDELEZ INTERNATIONAL INC-A (MDLZ) has a profitability rating of 7 / 10.
What are the PE and PB ratios of MONDELEZ INTERNATIONAL INC-A (MDLZ) stock?
The Price/Earnings (PE) ratio for MONDELEZ INTERNATIONAL INC-A (MDLZ) is 19.17 and the Price/Book (PB) ratio is 2.69.
How financially healthy is MONDELEZ INTERNATIONAL INC-A?
The financial health rating of MONDELEZ INTERNATIONAL INC-A (MDLZ) is 3 / 10.